COMMUNIQUÉS West-GlobeNewswire

Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
23/07/2026
-- FDA clearance of the IND, together with the previously cleared CTA, establishes a global Phase 1/2 clinical program for PM577a -- -- PM577a targets the H1069Q mutation in the ATP7B gene, the most prevalent WD-causing [...]
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
23/07/2026
WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
23/07/2026
DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT ) today announced that it will report its financial results for the first quarter ended June 30, 2026 on Thursday, August 6, 2026 before the [...]
Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call
23/07/2026
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the second quarter 2026 ended June 30, 2026, after market close on [...]
Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés
23/07/2026
Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés Ces dirigeants expérimentés du secteur apportent plusieurs décennies d’expertise en stratégie commerciale, services aux [...]
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
23/07/2026
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments Appointed industry leaders bring decades of experience across commercial strategy, patient services, launch readiness, and field force [...]
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
23/07/2026
BASEL, Switzerland and LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 6, 2026, to [...]
Codexis Announces Proposed Public Offering of Common Stock
23/07/2026
REDWOOD CITY, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics, today [...]
Crescent Biopharma Announces Grants of Inducement Awards
23/07/2026
WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
The Joint Corp. to Report 2026 Second Quarter Results on Thursday, August 6 and Host Conference Call and Webcast
23/07/2026
SCOTTSDALE, Ariz., July 23, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, announced it will report its 2026 [...]
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience
23/07/2026
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its previously announced special cash dividend (the “Cash Dividend”), declared in [...]
First American Equipment Finance renews HFMA Peer Review designation
23/07/2026
CHICAGO, July 23, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, First American Equipment Finance has once again achieved the “Peer [...]
Aeroflow Health’s Independent Research Identifies Why Mothers Miss Postpartum Care and What Health Plans Can Do About It
23/07/2026
Aeroflow’s research provides health plans with key insights into why new mothers miss the vital six-week postpartum visit ASHEVILLE, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health , a technology-enabled [...]
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
23/07/2026
New Taipei City, Taiwan, July 23, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization [...]
UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026
23/07/2026
SAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2026 results on Thursday, August 6, [...]
Guerbet : H1 2026 revenue.
23/07/2026
H1 2026 revenue H1 activity Revenue of €379.2m at 30 June 2026, nearly stable at CER 1 and on a like-for-like basis 2 (-0.1%) A 2.5% decline in Q2 at CER and on a like-for-like basis, marked by a solid recovery in the [...]
Guerbet : Chiffre d’affaires du 1er semestre 2026.
23/07/2026
Chiffre d’affaires du 1 er semestre 2026 Activité semestrielle Chiffre d’affaires au 30 juin 2026 de 379,2 M€, quasiment stable à TCC 1 et périmètre comparable 2 (-0,1%) Au deuxième trimestre, un repli de 2,5% à TCC et [...]
Invitation to Idorsia's HY 2026 Financial Reporting webcast and conference call
23/07/2026
Idorsia will publish its Half Year 2026 Financial Reporting on Thursday July 30, at 07:00 CEST. An investor webcast and conference call will be held to discuss the results on the same day. Date: Thursday, July 30, 2026 [...]
OKYO Pharma Announces Purchase of Shares by Director
23/07/2026
LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]

Pages